Paper5089955
The levels of factors II, VII, IX and X by antibody neutralization techniques in the plasma of patients receiving phenindione therapy.
Denson KW. Br J Haematol, 1971. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. The levels of factors II, VII, IX and X by antibody neutralization techniques in the plasma of patients receiving phenindione therapy. Papers, record 5089955. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5089955
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The levels of factors II, VII, IX and X by antibody neutralization techniques in the plasma of patients receiving phenindione therapy.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Factor IX | Major topic |
| Factor VII | Major topic |
| Factor X | Major topic |
| Phenindione | Major topic |
| Prothrombin | Major topic |
| Blood Platelets | |
| Chromatography, DEAE-Cellulose | |
| Factor VII Deficiency | |
| Hemophilia B | |
| Humans | |
| Methods | |
| Neutralization Tests | |
| Prothrombin Time | |
| Thromboplastin | |
| Venoms |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7027026 | Post-translational carboxylation of preprothrombin. | Mol Cell Biochem | 1981 | https://conductscience.org/library/papers/7027026 | PubMed |
| 6996772 | An immunological study of prothrombin in liver cirrhosis. | Blut | 1980 | https://conductscience.org/library/papers/6996772 | PubMed |
| 5050158 | Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques. | Blut | 1972 | https://conductscience.org/library/papers/5050158 | PubMed |
| 3435692 | Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3435692 | PubMed |
| 912109 | Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage. | Blut | 1977 | https://conductscience.org/library/papers/912109 | PubMed |
| 891569 | Antibody neutralizing material of factor VII during the first weeks of life. | Eur J Pediatr | 1977 | https://conductscience.org/library/papers/891569 | PubMed |
| 856873 | Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B. | J Clin Invest | 1977 | https://conductscience.org/library/papers/856873 | PubMed |
| 90058 | Combined functional and immunochemical analysis of normal and abnormal human factor X. | J Clin Invest | 1979 | https://conductscience.org/library/papers/90058 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F7 | 2155 | PubTator's text mining | https://conductscience.org/library/genes/2155 | NCBI Gene |
| F9 | 2158 | PubTator's text mining | https://conductscience.org/library/genes/2158 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5089955
GET https://conductscience.org/api/papers/v1/5089955/authors